Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) Return on Capital Employed (2021 - 2025)

SOPHiA GENETICS's Return on Capital Employed history spans 5 years, with the latest figure at 62.91% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 1524.0% to 62.91% in Q4 2025 year-over-year; TTM through Dec 2025 was 62.91%, a 1524.0% decrease, with the full-year FY2025 number at 65.27%, down 2202.0% from a year prior.
  • Return on Capital Employed hit 62.91% in Q4 2025 for SOPHiA GENETICS, down from 52.27% in the prior quarter.
  • Over the last five years, Return on Capital Employed for SOPH hit a ceiling of 23.91% in Q4 2021 and a floor of 62.91% in Q4 2025.
  • Historically, Return on Capital Employed has averaged 42.6% across 5 years, with a median of 41.88% in 2022.
  • Biggest five-year swings in Return on Capital Employed: tumbled -1593bps in 2022 and later skyrocketed 153bps in 2023.
  • Tracing SOPH's Return on Capital Employed over 5 years: stood at 23.91% in 2021, then crashed by -67bps to 39.85% in 2022, then dropped by -10bps to 43.92% in 2023, then fell by -9bps to 47.67% in 2024, then crashed by -32bps to 62.91% in 2025.
  • Business Quant data shows Return on Capital Employed for SOPH at 62.91% in Q4 2025, 52.27% in Q3 2025, and 52.74% in Q2 2025.